Table 4.
Variable | GDD | CPC | p-value† |
---|---|---|---|
IOP | |||
Pre-op | 27.8 ± 8.5 | 33.2 ± 8.6 | 0.0172* |
Final | 16.5 ± 8.7 | 14.5 ± 8.5 | |
Reduction | 11.3 ± 9.8 | 18.7 ± 12.0 | |
% Reduction* | 40.7% (p < 0.0001) | 56.3% (p < 0.0001) | |
Glaucoma Meds | |||
Pre-op | 3.88 ± 0.98 | 3.57 ± 1.03 | 0.3906 |
Final | 2.56 ± 1.32 | 2.62 ± 1.60 | |
Reduction | 1.31 ± 1.31 (p < 0.0001) | 0.95 ± 1.72 (p=0.0194) |
Tests for the difference in IOP reduction between treatment groups.
Test for difference in pre-operative and final IOP within the same treatment group
T-tests were used for continuous variables; a Cochran-Armitage Trend Test was used for the ordinal IOP Category variable